Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study
2011

Study of Immune Complexes and Genetic Variants in Ménière's Disease

Sample size: 268 publication Evidence: moderate

Author Information

Author(s): José A. Lopez-Escamez, Pablo Saenz-Lopez, Irene Gazquez, Antonia Moreno, Carlos Gonzalez-Oller, Andrés Soto-Varela, Sofía Santos, Ismael Aran, Herminio Perez-Garrigues, Águeda Ibañez, Miguel A. Lopez-Nevot

Primary Institution: Hospital de Poniente, El Ejido, Almería, Spain

Hypothesis

Do polymorphisms in CD16A and CD32 genes influence the presence of circulating immune complexes in patients with Ménière's disease?

Conclusion

Polymorphisms of CD16A and CD32 genes are not associated with the onset of Ménière's disease.

Supporting Evidence

  • Elevated circulating immune complexes were found in 7% of patients with Ménière's disease.
  • No differences in allelic frequency for CD16A and CD32 were found between patients and controls.
  • The genotype AC of CD16A was significantly more frequent in Mediterranean controls than in patients.

Takeaway

The study looked at whether certain genes affect a disease called Ménière's disease, but found that they don't seem to make a difference.

Methodology

The study analyzed SNPs in CD16A and CD32 genes in two cohorts of patients with Ménière's disease and compared them to controls.

Limitations

The study could not demonstrate an association between the genotype AA of CD16A and elevated circulating immune complexes.

Participant Demographics

Patients were Caucasian, with 156 from the southeast and 112 from Galicia, Spain.

Statistical Information

P-Value

p = 0.02 for AC genotype of CD16A

Confidence Interval

OR = 0.63 (0.44-0.91)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2350-12-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication